Trigeminal neuralgia and persistent idiopathic facial pain

Expert Review of Neurotherapeutics

Volumn 11, Issue 11, 2011, Pages 1619-1629

  Obermann, Mark ^a   Holle, Dagny ^a   Katsarava, Zaza ^a  

^a UNIVERSITY OF DUISBURG ESSEN   (Germany)

Author keywords

atypical facial pain; differential diagnosis; pathophysiology; persistent idiopathic facial pain; treatment; trigeminal neuralgia

Indexed keywords

ANTICONVULSIVE AGENT; BACLOFEN; BOTULINUM TOXIN A; CALCITONIN; CARBAMAZEPINE; CLONAZEPAM; ETIRACETAM; FLUOXETINE; GABAPENTIN; HORMONE; HYDROCODONE; LAMOTRIGINE; OXCARBAZEPINE; PHENYTOIN; PIMOZIDE; PLACEBO; PREGABALIN; SEROTONIN UPTAKE INHIBITOR; SUMATRIPTAN; TOCAINIDE; TOPIRAMATE; TRICYCLIC ANTIDEPRESSANT AGENT; VALPROIC ACID; VENLAFAXINE; ZOLMITRIPTAN;

ACUPUNCTURE; ADD ON THERAPY; ALLODYNIA; ANESTHESIA DOLOROSA; ASEPTIC MENINGITIS; BLOOD VESSEL DECOMPRESSION; BRAIN DEPTH STIMULATION; CLINICAL EVALUATION; CLINICAL FEATURE; CLINICAL TRIAL (TOPIC); COGNITIVE THERAPY; CORNEA DISEASE; CORNEAL NUMBNESS; DIFFERENTIAL DIAGNOSIS; DIFFUSION TENSOR IMAGING; DISEASE ASSOCIATION; DRUG EFFICACY; DYSESTHESIA; FACE PAIN; GAMMA KNIFE RADIOSURGERY; HEARING LOSS; HUMAN; HYPONATREMIA; MENTAL DISEASE; META ANALYSIS (TOPIC); NERVE DECOMPRESSION; NONHUMAN; NUCLEAR MAGNETIC RESONANCE IMAGING; PAIN; PAIN ASSESSMENT; PATHOPHYSIOLOGY; PERSISTENT IDIOPATHIC FACIAL PAIN; PREVALENCE; PULSED RADIOFREQUENCY; QUALITY OF LIFE; RADIOFREQUENCY RADIATION; RADIOFREQUENCY THERMOCOAGULATION; RANDOMIZED CONTROLLED TRIAL (TOPIC); REVIEW; RISK FACTOR; SENSORY DYSFUNCTION; STEVENS JOHNSON SYNDROME; SURGICAL TECHNIQUE; TOXIC EPIDERMAL NECROLYSIS; TRANSCRANIAL MAGNETIC STIMULATION; TRANSCUTANEOUS NERVE STIMULATION; TRIGEMINAL AUTONOMIC CEPHALALGIA; TRIGEMINAL NERVE; TRIGEMINUS NEURALGIA;

FACIAL PAIN; HUMANS; TRIGEMINAL NEURALGIA;

EID: 80054922199     PISSN: 14737175     EISSN: 17448360     Source Type: Journal    
DOI: 10.1586/ern.11.156     Document Type: Review

References (104)

1. Goulet JP, Lavigne GJ, Lund JP. Jaw pain prevalence among French-speaking Canadians in Quebec and related symptoms of temporomandibular disorders. J Dent. Res. 74(11), 1738-1744 (1995)
2. Macfarlane TV, Blinkhorn AS, Davies RM, Kincey J, Worthington HV. Oro-facial pain in the community: prevalence and associated impact. Community Dent. Oral Epidemiol. 30(1), 52-60 (2002)
3. McMillan AS, Wong MC, Zheng J, Lam CL. Prevalence of orofacial pain and treatment seeking in Hong Kong Chinese. J Orofac. Pain. 20(3), 218-225 (2006)
4. Ng KF, Tsui SL, Chan WS. Prevalence of common chronic pain in Hong Kong adults. Clin. J Pain 18(5), 275-281 (2002)
5. Riley JL III, Gilbert GH, Heft MW. Orofacial pain symptom prevalence: selective sex differences in the elderly? Pain 76(1-2), 97-104 (1998)
6. Lipton JA, Ship JA, Larach-Robinson D. Estimated prevalence and distribution of reported orofacial pain in the United States. J Am. Dent. Assoc. 124(10), 115-121 (1993)
7. Benoliel R, Birman N, Eliav E, Sharav Y. the international classification of headache disorders: accurate diagnosis of orofacial pain? Cephalalgia 28(7), 752-762 (2008)
8. Forssell H, Tenovuo O, Silvoniemi P, Jaaskelainen SK. Differences and similarities between atypical facial pain and trigeminal neuropathic pain. Neurology 69(14), 1451-1459 (2007)
9. International Headache Society. The international classification of headache disorders: 2nd edition. Cephalalgia 24(Suppl. 1), 9-160 (2004)
10. De Simone R, Marano E, Brescia Morra V et al. A clinical comparison of trigeminal neuralgic pain in patients with and without underlying multiple sclerosis. Neurol. Sci. 26(Suppl. 2), S150-S151 (2005)
11. Szapiro J Jr, Sindou M, Szapiro J. Prognostic factors in microvascular decompression for trigeminal neuralgia. Neurosurgery 17(6), 920-929 (1985)
12. Obermann M, Yoon MS, Sensen K, Maschke M, Diener HC, Katsarava Z. Efficacy of pregabalin in the treatment of trigeminal neuralgia. Cephalalgia 28(2), 174-181 (2008)
13. Sandell T, Eide PK. Effect of microvascular decompression in trigeminal neuralgia patients with or without constant pain. Neurosurgery 63(1), 93-99 (2008)
14. Frazier C, Russel E. Neuralgia of the face: an analysis of 754 cases with relation to pain and other sensory phenomena before and after operation. Arch. Neurol. Psychiatry 11, 557-563 (1924)
15. Gouda JJ, Brown JA. Atypical facial pain and other pain syndromes. Differential diagnosis and treatment. Neurosurg. Clin. N. Am. 8(1), 87-100 (1997)
16. Sardella A, Demarosi F, Barbieri C, Lodi G. An up-to-date view on persistent idiopathic facial pain. Minerva Stomatol. 58(6), 289-299 (2009)
17. Koopman JS, Dieleman JP, Huygen FJ, de Mos M, Martin CG, Sturkenboom MC. Incidence of facial pain in the general population. Pain 147(1-3), 122-127 (2009)
18. Aggarwal VR, Macfarlane GJ, Farragher TM, McBeth J. Risk factors for onset of chronic oro-facial pain -results of the North Cheshire oro-facial pain prospective population study. Pain 149(2), 354-359 (2010)
19. Yoshimasu F, Kurland LT, Elveback LR. Tic douloureux in Rochester, Minnesota, 1945-1969. Neurology 22(9), 952-956 (1972)
20. Katusic S, Williams DB, Beard CM, Bergstralh EJ, Kurland LT. Epidemiology and clinical features of idiopathic trigeminal neuralgia and glossopharyngeal neuralgia: similarities and differences, Rochester, Minnesota, 1945-1984. Neuroepidemiology 10(5-6), 276-281 (1991)
21. MacDonald BK, Cockerell OC, Sander J, Shorvon SD. The incidence and lifetime prevalence of neurological disorders in a prospective community-based study in the UK. Brain 123, 665-676 (2000)
22. Mueller D, Obermann M, Yoon MS et al. Prevalence of trigeminal neuralgia and persistent idiopathic facial pain: a population-based study. Cephalalgia DOI: 10.1177/0333102411424619 (2011) (Epub ahead of print)
23. Sjaastad O, Bakketeig LS. The rare, unilateral headaches. Vaga study of headache epidemiology. J Headache Pain 8(1), 19-27 (2007)
24. Melis M, Lobo SL, Ceneviz C et al. Atypical odontalgia: a review of the literature. Headache 43(10), 1060-1074 (2003)
25. Kavuk I, Yavuz A, Cetindere U, Agelink MW, Diener HC. Epidemiology of chronic daily headache. Eur J. Med. Res. 8(6), 236-240 (2003)
26. Dao TT, LeResche L. Gender differences in pain. J Orofac. Pain. 14(3), 169-184 (2000)
27. Marinkovic S, Todorovic V, Gibo H et al. The trigeminal vasculature pathology in patients with neuralgia. Headache 47(9), 1334-1339 (2007)
28. Burchiel KJ. Abnormal impulse generation in focally demyelinated trigeminal roots. J Neurosurg. 53(5), 674-683 (1980)
29. Rappaport ZH, Govrin-Lippmann R, Devor M. An electron-microscopic analysis of biopsy samples of the trigeminal root taken during microvascular decompressive surgery. Stereotact. Funct. Neurosurg. 68(1-4 Pt 1), 182-186 (1997)
30. Peker S, Kurtkaya O, Uzun I, Pamir MN. Microanatomy of the central myelin-peripheral myelin transition zone of the trigeminal nerve. Neurosurgery 59(2), 354-359 (2006)
31. Rushton JG, Macdonald HN. Trigeminal neuralgia; special considerations of nonsurgical treatment. J Am. Med. Assoc. 165(5), 437-440 (1957)
32. Herweh C, Kress B, Rasche D et al. Loss of anisotropy in trigeminal neuralgia revealed by diffusion tensor imaging. Neurology 68(10), 776-778 (2007)
33. Jannetta PJ. Arterial compression of the trigeminal nerve at the pons in patients with trigeminal neuralgia. J Neurosurg. 26(1 Suppl.), 159-162 (1967)
34. Adamczyk M, Bulski T, Sowinska J, Furmanek A, Bekiesinska-Figatowska M. Trigeminal nerve -artery contact in people without trigeminal neuralgia -MR study. Med. Sci. Monit. 13(Suppl. 1), 38-43 (2007)
35. Kakizawa Y, Seguchi T, Kodama K et al. Anatomical study of the trigeminal and facial cranial nerves with the aid of 3.0-tesla magnetic resonance imaging. J Neurosurg. 108(3), 483-490 (2008)
36. Gronseth G, Cruccu G, Alksne J et al. Practice parameter: the diagnostic evaluation and treatment of trigeminal neuralgia (an evidence-based review): report of the Quality Standards Subcommittee of the American Academy of Neurology and the European Federation of Neurological Societies. Neurology 71(15), 1183-1190 (2008)
37. Hamlyn PJ, King TT. Neurovascular compression in trigeminal neuralgia: a clinical and anatomical study. J Neurosurg. 76(6), 948-954 (1992)
38. Siqueira SR, Alves B, Malpartida HM, Teixeira MJ, Siqueira JT. Abnormal expression of voltage-gated sodium channels Nav1.7, Nav1.3 and Nav1.8 in trigeminal neuralgia. Neuroscience 164(2), 573-577 (2009)
39. Obermann M, Yoon MS, Ese D et al. Impaired trigeminal nociceptive processing in patients with trigeminal neuralgia. Neurology 69(9), 835-841 (2007)
40. Borsook D, Moulton EA, Pendse G et al. Comparison of evoked vs. spontaneous tics in a patient with trigeminal neuralgia (tic doloureux). Mol. Pain 3, 34 (2007)
41. Moisset X, Villain N, Ducreux D et al. Functional brain imaging of trigeminal neuralgia. Eur J. Pain 15(2), 124-131 (2011)
42. Hu WH, Zhang K, Zhang JG. Atypical trigeminal neuralgia: a consequence of central sensitization? Med. Hypotheses 75(1), 65-66 (2010)
43. Li ST, Wang X, Pan Q et al. Studies on the operative outcomes and mechanisms of microvascular decompression in treating typical and atypical trigeminal neuralgia. Clin. J Pain 21(4), 311-316 (2005)
44. Siccoli MM, Bassetti CL, Sandor PS. Facial pain: clinical differential diagnosis. Lancet Neurol. 5(3), 257-267 (2006)
45. Jensen TS, Baron R, Haanpaa M et al. A new definition of neuropathic pain. Pain DOI: 10.1016/j.pain.2011.06.017 (2011) (Epub ahead of print)
46. Feinmann C, Harris M. Psychogenic facial pain. Part 1: the clinical presentation. Br. Dent. J 156(5), 165-168 (1984)
47. Remick RA, Blasberg B. Psychiatric aspects of atypical facial pain. J Can. Dent. Assoc. 51(12), 913-916 (1985)
48. Schmidt-Wilcke T, Hierlmeier S, Leinisch E. Altered regional brain morphology in patients with chronic facial pain. Headache 50(8), 1278-1285 (2010)
49. Derbyshire SW, Jones AK, Devani P et al. Cerebral responses to pain in patients with atypical facial pain measured by positron emission tomography. J Neurol. Neurosurg. Psychiatry 57(10), 1166-1172 (1994)
50. Hagelberg N, Forssell H, Aalto S et al. Altered dopamine D2 receptor binding in atypical facial pain. Pain 106(1-2), 43-48 (2003)
51. Jääskeläinen SK, Forssell H, Tenovuo O. Electrophysiological testing of the trigeminofacial system: aid in the diagnosis of atypical facial pain. Pain 80, 191-200 (1999)
52. Didier H, Marchetti C, Borromeo G, Tullo V, Bussone G, Santoro F. Persistent idiopathic facial pain: multidisciplinary approach and assumption of comorbidity. Neurol. Sci. 31(Suppl. 1), S189-S195 (2010)
53. Cornelissen P, van Kleef M, Mekhail N, Day M, van Zundert J. Evidence-based interventional pain medicine according to clinical diagnoses. 3. Persistent idiopathic facial pain. Pain Pract. 9(6), 443-448 (2009)
54. Cohen AS, Matharu MS, Goadsby PJ. Short-lasting unilateral neuralgiform headache attacks with conjunctival injection and tearing (SUNCT) or cranial autonomic features (SUNA) -a prospective clinical study of SUNCT and SUNA. Brain 129(Pt 10), 2746-2760 (2006)
55. Evans RW, Agostoni E. Persistent idiopathic facial pain. Headache 46(8), 1298-1300 (2006)
56. Sarlani E, Schwartz AH, Greenspan JD, Grace EG. Facial pain as first manifestation of lung cancer: a case of lung cancer-related cluster headache and a review of the literature. J Orofac. Pain. 17(3), 262-267 (2003)
57. Cruccu G, Gronseth G, Alksne J et al. AAN-EFNS guidelines on trigeminal neuralgia management. Eur J. Neurol. 15(10), 1013-1028 (2008)
58. Cha J, Kim ST, Kim HJ et al. Trigeminal neuralgia: assessment with T2 VISTA and FLAIR VISTA fusion imaging. Eur Radiol. DOI: 10.1007/s00330-011-2216-1 (2011) (Epub ahead of print)
59. Miller J, Acar F, Hamilton B, Burchiel K. Preoperative visualization of neurovascular anatomy in trigeminal neuralgia. J Neurosurg. 108(3), 477-482 (2008)
60. Kuncz A, Voros E, Barzo P et al. Comparison of clinical symptoms and magnetic resonance angiographic (MRA) results in patients with trigeminal neuralgia and persistent idiopathic facial pain. Medium-term outcome after microvascular decompression of cases with positive MRA findings. Cephalalgia 26(3), 266-276 (2006)
61. Yang M ZM, He L, Chen N, Zakrzewska JM. Non-antiepileptic drugs for trigeminal neuralgia. Cochrane Database Syst. Rev. 1, CD004029 (2011)
62. Zakrzewska JM, Jorns TP, Spatz A. Patient led conferences -who attends, are their expectations met and do they vary in three different countries? Eur. J Pain 13(5), 486-491 (2009)
63. Campbell FG, Graham JG, Zilkha KJ. Clinical trial of carbazepine (tegretol) in trigeminal neuralgia. J Neurol. Neurosurg. Psychiatry 29(3), 265-267 (1966)
64. Killian JM, Fromm GH. Carbamazepine in the treatment of neuralgia. Use of side effects. Arch. Neurol. 19(2), 129-136 (1968)
65. Nicol CF. A four year double-blind study of tegretol in facial pain. Headache 9(1), 54-57 (1969)
66. Rockliff BW, Davis EH. Controlled sequential trials of carbamazepine in trigeminal neuralgia. Arch. Neurol. 15(2), 129-136 (1966)
67. Beydoun A. Safety and efficacy of oxcarbazepine: results of randomized, double-blind trials. Pharmacotherapy 20(8 Pt 2), S152-S158 (2000)
68. Taylor JC, Brauer S, Espir ML. Long-term treatment of trigeminal neuralgia with carbamazepine. Postgrad. Med. J 57(663), 16-18 (1981)
69. Khan OA. Gabapentin relieves trigeminal neuralgia in multiple sclerosis patients. Neurology 51(2), 611-614 (1998)
70. Zakrzewska JM, Chaudhry Z, Nurmikko TJ, Patton DW, Mullens EL. Lamotrigine (Lamictal) in refractory trigeminal neuralgia: results from a double-blind placebo controlled crossover trial. Pain 73, 223-230 (1997)
71. Fromm GH, Terrence CF, Chattha AS. Baclofen in the treatment of trigeminal neuralgia: double-blind study and long-term follow-up. Ann Neurol. 15, 240-244 (1984)
72. Lindstrom P, Lindblom U. The analgesic effect of tocainide in trigeminal neuralgia. Pain 28(1), 45-50 (1987)
73. Domingues RB, Kuster GW, Aquino CC. Treatment of trigeminal neuralgia with low doses of topiramate. Arq. Neuropsiquiatr. 65(3B), 792-794 (2007)
74. Mitsikostas DD, Pantes GV, Avramidis TG et al. An observational trial to investigate the efficacy and tolerability of levetiracetam in trigeminal neuralgia. Headache 50(8), 1371-1377 (2010)
75. Jorns TP, Johnston A, Zakrzewska JM. Pilot study to evaluate the efficacy and tolerability of levetiracetam (Keppra) in treatment of patients with trigeminal neuralgia. Eur J. Neurol. 16(6), 740-744 (2009)
76. Kayser V, Aubel B, Hamon M, Bourgoin S. The antimigraine 5-HT 1B/1D receptor agonists, sumatriptan, zolmitriptan and dihydroergotamine, attenuate pain-related behaviour in a rat model of trigeminal neuropathic pain. Br. J Pharmacol. 137(8), 1287-1297 (2002)
77. Kanai A, Saito M, Hoka S. Subcutaneous sumatriptan for refractory trigeminal neuralgia. Headache 46(4), 577-582 (2006)
78. Aoki KR. Review of a proposed mechanism for the antinociceptive action of botulinum toxin type A. Neurotoxicology 26(5), 785-793 (2005)
79. Piovesan EJ, Teive HG, Kowacs PA, Della Coletta MV, Werneck LC, Silberstein SD. An open study of botulinum-A toxin treatment of trigeminal neuralgia. Neurology 65(8), 1306-1308 (2005)
80. Liu H, Li H, Xu M, Chung KF, Zhang SP. A systematic review on acupuncture for trigeminal neuralgia. Altern. Ther. Health Med. 16(6), 30-35 (2010)
81. Khedr EM, Kotb H, Kamel NF, Ahmed MA, Sadek R, Rothwell JC. Longlasting antalgic effects of daily sessions of repetitive transcranial magnetic stimulation in central and peripheral neuropathic pain. J Neurol. Neurosurg. Psychiatry 76(6), 833-838 (2005)
82. Antal A, Terney D, Kuhnl S, Paulus W. Anodal transcranial direct current stimulation of the motor cortex ameliorates chronic pain and reduces short intracortical inhibition. J Pain Symptom Manage. 39(5), 890-903 (2010)
83. Zaghi S, DaSilva AF, Acar M, Lopes M, Fregni F. One-year rTMS treatment for refractory trigeminal neuralgia. J Pain Symptom Manage. 38(4), e1-e5 (2009)
84. List T, Axelsson S, Leijon G. Pharmacologic interventions in the treatment of temporomandibular disorders, atypical facial pain, and burning mouth syndrome. A qualitative systematic review. J Orofac. Pain. 17(4), 301-310 (2003)
85. Harrison S, Glover L, Maslin L, Feinmann C, Pearce S, Harris M. A comparison of antidepressant medication alone and in conjunction with cognitive behavioral therapy for chronic idiopathic facial pain. In: Proceedings of the 8th World Congress on Pain. Volume 8. Jensen T, Turner J, Weinsenfeld-Halin Z (Eds). IASP Press, Seattle, WA, USA (1997)
86. Forssell H, Tasmuth T, Tenovuo O, Hampf G, Kalso E. Venlafaxine in the treatment of atypical facial pain: a randomized controlled trial. J Orofac. Pain. 18(2), 131-137 (2004)
87. Volcy M, Rapoport AM, Tepper SJ, Sheftell FD, Bigal ME. Persistent idiopathic facial pain responsive to topiramate. Cephalalgia 26(4), 489-491 (2006)
88. Schwartz G, Galonski M, Gordon A, Shandling M, Mock D, Tenenbaum HC. Effects of salmon calcitonin on patients with atypical (idiopathic) facial pain: a randomized controlled trial. J Orofac. Pain. 10(4), 306-315 (1996)
89. Harrison SD, Balawi SA, Feinmann C, Harris M. Atypical facial pain: a double-blind placebo-controlled crossover pilot study of subcutaneous sumatriptan. Eur Neuropsychopharmacol. 7(2), 83-88 (1997)
90. al Balawi S, Tariq M, Feinmann C. A double-blind, placebo-controlled, crossover, study to evaluate the efficacy of subcutaneous sumatriptan in the treatment of atypical facial pain. Int. J Neurosci. 86(3-4), 301-309 (1996)
91. Kanpolat Y, Savas A, Ugur HC, Bozkurt M. The trigeminal tract and nucleus procedures in treatment of atypical facial pain. Surg. Neurol. 64(Suppl. 2), S96-S100 (2005)
92. Eriksson MB, Sjolund BH, Sundbarg G. Pain relief from peripheral conditioning stimulation in patients with chronic facial pain. J Neurosurg. 61(1), 149-155 (1984)
93. Bayer E, Racz GB, Miles D, Heavner J. Sphenopalatine ganglion pulsed radiofrequency treatment in 30 patients suffering from chronic face and head pain. Pain Pract. 5(3), 223-227 (2005)
94. Neuman SA, Eldrige JS, Hoelzer BC. Atypical facial pain treated with upper thoracic dorsal column stimulation. Clin. J Pain 27(6), 556-558 (2011)
95. Spatz AL, Zakrzewska JM, Kay EJ. Decision analysis of medical and surgical treatments for trigeminal neuralgia: how patient evaluations of benefits and risks affect the utility of treatment decisions. Pain 131(3), 302-310 (2007)
96. Kalkanis SN, Eskandar EN, Carter BS, Barker FG 2nd. Microvascular decompression surgery in the United States, 1996 to 2000: mortality rates, morbidity rates, and the effects of hospital and surgeon volumes. Neurosurgery 52(6), 1251-1261 (2003)
97. Zakrzewska JM, Lopez BC. Quality of reporting in evaluations of surgical treatment of trigeminal neuralgia: recommendations for future reports. Neurosurgery 53(1), 110-120 (2003)
98. Zakrzewska JM, Jassim S, Bulman JS. A prospective, longitudinal study on patients with trigeminal neuralgia who underwent radiofrequency thermocoagulation of the Gasserian ganglion. Pain 79, 51-58 (1999)
99. Kabatas S, Karasu A, Civelek E, Sabanci AP, Hepgul KT, Teng YD. Microvascular decompression as a surgical management for trigeminal neuralgia: long-term follow-up and review of the literature. Neurosurg. Rev. 32(1), 87-94 (2009)
100. Little AS, Shetter AG, Shetter ME, Bay C, Rogers CL. Long-term pain response and quality of life in patients with typical trigeminal neuralgia treated with gamma knife stereotactic radiosurgery. Neurosurgery 63(5), 915-923 (2008)
101. Sindou M, Leston JM, Decullier E, Chapuis F. Microvascular decompression for trigeminal neuralgia: the importance of a noncompressive technique -Kaplan-Meier analysis in a consecutive series of 330 patients. Neurosurgery 63(4 Suppl. 2), 341-350 (2008)
102. Kanpolat Y, Kahilogullari G, Ugur HC, Elhan AH. Computed tomography-guided percutaneous trigeminal tractotomy-nucleotomy. Neurosurgery 63(1 Suppl. 1), ONS147-ONS153 (2008)
103. Tatli M, Sindou M. Anatomoradiological landmarks for accuracy of radiofrequency thermorhizotomy in the treatment of trigeminal neuralgia. Neurosurgery 63(1 Suppl. 1), ONS129-ONS137 (2008)
104. Obermann M, Katsarava Z. Update on trigeminal neuralgia. Expert Rev. Neurother. 9(3), 323-329 (2009)